Extracellular vesicles derived from TNF-α-preconditioned mesenchymal stem cells mitigate inflammatory retinal injury
Extracellular Vesicles and Circulating Nucleic Acids · 17.03.2026 · 7 (1) · 377-93
DOI: 10.20517/evcna.2025.159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Extracellular Vesicles and Circulating Nucleic Acids, online erschienen am 17.03.2026. Verfasst von Zhuxin Jia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
To evaluate the therapeutic efficacy and mechanisms of tumor necrosis factor-alpha (TNF-α) preconditioned mesenchymal stem cells (MSCs)-derived small extracellular vesicles (hereafter abbreviated as T-sEV), along with the control small extracellular vesicles (sEV, representing vesicles from naive/unstimulated MSCs), in mitigating inflammatory retinal injury.
Methods
T-sEV were isolated from TNF-α-preconditioned MSCs and systematically characterized. Small RNA sequencing was performed to identify the microRNA (miRNA) cargo of T-sEV. The effect of T-sEV on lipopolysaccharide (LPS)-induced M1 macrophage polarization was assessed by flow cytometry. Integrated bioinformatic analysis linked T-sEV miRNAs to macrophage transcriptome changes. T-sEV were administered intravitreally in a murine sodium iodate (NaIO3)-induced retinal degeneration model. Electroretinography (ERG), optical coherence tomography (OCT), flow cytometry, intraocular pressure (IOP) and systemic examinations were conducted.
Results
T-sEV exhibited an enrichment of anti-inflammatory miRNAs, notably miR-146a-5p. They were efficiently internalized by macrophages, significantly suppressing M1 polarization, as evidenced by the decreased percentage of cluster of differentiation (CD)11b+/CD86+ cells (29.60% ± 2.30%) compared to the sEV group (34.90% ± 1.57%, P < 0.05). Analysis showed T-sEV miRNAs targeted and downregulated key pro-inflammatory genes such as Cd86 and Il1r1. In vivo, T-sEV treatment significantly preserved retinal a- and b-wave amplitudes and structural integrity. T-sEV treatment markedly reduced retinal macrophage infiltration, decreasing the proportion of F4/80+CD11b+ cells to 0.38% ± 0.13%, significantly lower than in the sEV group (1.66% ± 0.47%, P < 0.01). No adverse effects on IOP or systemic markers were observed.
Conclusion
TNF-α preconditioning enhances MSC-derived sEV therapeutic capacity by enriching their anti-inflammatory miRNAs. T-sEV suppress pro-inflammatory macrophage activation and provide superior neuroprotection in a retinal degeneration model, indicating a safe and promising cell-free therapeutic strategy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
- National Engineering Research Center for Ophthalmology, Beijing 102600, China.
- Engineering Research Center of Ophthalmic Equipment and Materials, Ministry of Education, Beijing 100176, China.
- Chinese Institutes for Medical Research, Beijing 100071, China.
Zitieren
APA
Jia, Z., Luan, F., Shi, J., Tao, Y., & Tian, Y. (2026). Extracellular vesicles derived from TNF-α-preconditioned mesenchymal stem cells mitigate inflammatory retinal injury. Extracellular Vesicles and Circulating Nucleic Acids, 7(1), 377-93. https://doi.org/10.20517/evcna.2025.159
Vancouver
Jia Z, Luan F, Shi J, Tao Y, Tian Y. Extracellular vesicles derived from TNF-α-preconditioned mesenchymal stem cells mitigate inflammatory retinal injury. Extracellular Vesicles and Circulating Nucleic Acids. 2026;7(1):377-93. doi:10.20517/evcna.2025.159
BibTeX
@article{Jia2026,
author = {Jia, Zhuxin and Luan, Fuxiao and Shi, Jingyi and Tao, Yong and Tian, Ying},
title = {Extracellular vesicles derived from TNF-α-preconditioned mesenchymal stem cells mitigate inflammatory retinal injury},
journal = {Extracellular Vesicles and Circulating Nucleic Acids},
year = {2026},
volume = {7},
number = {1},
pages = {377--93},
doi = {10.20517/evcna.2025.159}
}
EUVIMED